We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
205 hedge funds and large institutions have $1.07B invested in ANI Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 69 increasing their positions, 60 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 60
1.89% more ownership
Funds ownership: 89.96% → 91.85% (+1.9%)
0% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 31
1% less funds holding
Funds holding: 208 → 205 (-3)
6% less capital invested
Capital invested by funds: $1.14B → $1.07B (-$71.7M)
69% less call options, than puts
Call options by funds: $188K | Put options by funds: $597K
Holders
205
Holders Change
-3
Holders Change %
-1.44%
% of All Funds
2.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
69
Reduced
60
Closed
31
Calls
$188K
Puts
$597K
Net Calls
-$409K
Net Calls Change
-$337K
Top Buyers
| 1 |
Millennium Management
New York
|
+$27.2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.7M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$13.7M |
| 4 |
SCM
Sio Capital Management
New York
|
+$9.19M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.28M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$32.5M |
| 2 |
JP Morgan Chase
New York
|
-$16.5M |
| 3 |
Morgan Stanley
New York
|
-$10M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$9.34M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$7.61M |
